X

Dabur India Ltd. Stock Analysis

Large Cap
Evaluated by 8798 users | BSE: 500096 | NSE: DABUR |
Household & Personal Products
Dabur India, that made its beginnings with a small pharmacy, but has continued to learn and grow to a commanding status in the industry is now the fourth largest FMCG company of the country with a turnover of Rs2,396 crore. It was established over 100 years ago presently catering to...
1. Right Stock
Very Good
2. Right Price
3. Right Time

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Dabur India Ltd. has performed well in majority of the past ten years indicating its past ten year financial track record is very good
Value Creation
Value Creation Index Colour Code Guide
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Capital Employed 32.61%25.69%25.93%26.94%27.24%27.18%23.62%22.04%23.48%22.64%
Value Creation Index 2.972.102.052.172.202.201.781.591.761.66
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 4,1055,3056,1697,0757,8277,7807,6147,7228,5158,685
Y-o-Y Gr. Rt.-29.3%16.3%14.7%10.6%-0.6%-2.1%1.4%10.3%2%
Adjusted EPS (Rs.) 3.223.684.385.186.017.017.037.628.438.47
Y-o-Y Gr. Rt.-14.3%19%18.3%16%16.6%0.3%8.4%10.6%0.5%
Book Value per Share (Rs.) 6.758.9511.6214.7718.823.1926.9331.8731.4636.85
Adjusted Net Profit 5616417639031,0551,2321,2381,3421,4881,497
Net Op. Cash Flow (Rs. Cr.) 5315978701,0981,0471,1871,2271,0921,4991,614
Debt to Cash Flow from Ops 1.981.871.450.870.920.670.790.860.470.32
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Dabur India Ltd. should be analysed on a Consolidated basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales 8.7%2.1%4.5%2%
Adjusted EPS 11.3%7.1%6.4%0.5%
Book Value per Share 20.814.41117.1
Share Price 20% 13.7% 17% 10%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Equity (%) 48.1841.239.9737.9335.0732.7627.4525.4326.2524.46
Operating Profit Margin (%) 18.7116.2516.0816.4216.8619.5219.8521.0720.4620.69
Net Profit Margin (%) 13.6712.0612.4112.813.5215.8816.317.4217.5117.27
Debt to Equity 0.890.720.620.370.290.190.210.170.130.08
Working Capital Days 110123121112118136124102102114
Cash Conversion Cycle 1134372419179-4-12
Corporate Governance What do we look at?
Corporate Governance
Board Credentials
Promoter's holding
Transparency
Integrity
Entity Percentage Holding
Promoters 67.87%
Institutions 24.98%
Non-Institutions 7.15%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

MoneyWorks4Me analysed the past 10-year performance of Dabur India Ltd. and arrived at the following conclusion:

Past 10 year's financial track record indicates that Dabur India Ltd. is a good quality company. However, for specific investment actions please connect with your investment advisor.

The 5-year analysis of Dabur India Ltd.'s performance infers:

Dabur India Ltd. earnings have grown by 7.1%, whereas share price has appreciated 13.7% CAGR over the past five years, indicating the company's share price is likely overvalued. However, for specific investment actions please connect with your investment advisor.

We analysed the performance of Dabur India Ltd. share prices over the last 10 years. Here is what we found out:

Dabur India Ltd. share price has appreciated 17.9% annually over the past ten years.

Dabur India, that made its beginnings with a small pharmacy, but has continued to learn and grow to a commanding status in the industry is now the fourth largest FMCG company of the country with a turnover of Rs2,396 crore. It was established over 100 years ago presently catering to health care,personal care & food segment.

In April 2009, the Hon'ble High Court of Judicature at Delhi has sanctioned the Scheme of Amalgamation of Fem Care Pharma with

Dabur India, that made its beginnings with a small pharmacy, but has continued to learn and grow to a commanding status in the industry is now the fourth largest FMCG company of the country with a turnover of Rs2,396 crore. It was established over 100 years ago presently catering to health care,personal care & food segment.

In April 2009, the Hon'ble High Court of Judicature at Delhi has sanctioned the Scheme of Amalgamation of Fem Care Pharma with Dabur India.

In July 2010, the Company's wholly owned subsidiary Dabur International entered into an agreement to acquire 100% stake in leading personal care Company in Turkey i.e. Hobi Group firms- Hobi Kozmetik, Zeki Plastik and Ra Pazarlama at a total consideration of US$ 69 million.

Products

Under health care products it has brands like Hajmola, Pudin Hara, Dabur Chyawanprash, Glucose D, Dabur Lal tail,etc.

In home care range consist of product like Odinil,Odomos,odopic,etc.

Under personal care range it has product like Vatika,Gulabri,Dabur Red Toothpaste,etc.

In food range it has brands like Real Active ,HOMMADE-range of ready made pastes, soups, coconut milk & tomato puree

Dabur has guar gum plant,a natural gum used in foods & industrial applications.

Dabur also produces ayurvedic medicines.

Dabur has global presence in 50 countries,products are  available in the markets of Middle East, South-East Asia, Africa, the European Union and America.

Milestones:

Dabur Ranked Among India’s Most Trusted Brands Of 2007 By Economic Times-Brand Equity.

Dabur is amongst Top Three Most Respected FMCG Companies-according to the survey conducted by Businessworld magazine.

Dabur Real Bags Gold In Reader's Digest Trusted Brand Awards.

In 2010, Dabur Amla Hair Oils enters Limca Book of Records for achieving a record feat of hosting the longest ever non-stop head massage marathon.

'2010
- Dabur Acquires Namaste Group For $100 Million''.
- Dabur Chyawanprash was launched in Orange and Mango flavoured variants.
- Dabur Amla Hair Oils enters Limca Book of Records for achieving a record feat of hosting the longest ever non-stop head massage marathon.

2011
- Dabur enters professional skin care market with the launch of OxyLife Professional Facial Kit, created exclusively for professional use.
- Dabur India acquires 30-Plus from Ajanta Pharma.
- Dabur India Ltd sets up new subsidiary in Sri Lanka Dabur Lanka (Pvt.) Ltd.
- Dabur India Ltd launches Dabur Almond Hair Oil.

In January, 2011, Dermoviva Skin Essentials Inc., the company's wholly owned subsidiary, has completed the acquisition process of leading personal care companies of Namaste Group, US by acquiring 100% stake in Namaste Laboratories, Hair Rejuvenation & Revitalization Nigeria, Healing Hair Laboratories International LLC and Urban Laboratories International LLC.

In April, 2011, Dabur entered into the hand sanitizer market under its 'Fem Care' brand to take on the likes of Reckitt Benckiser and Hindustan Unilever, which were currently dominating the market.

In 2011, Dabur enters professional skin care market with the launch of OxyLife Professional Facial Kit, created exclusively for professional use.

During 2011, Dabur India Ltd. launches its first-ever online shopping portal www.daburuveda.com With this, Dabur is the first Indian FMCG company to launch a dedicated online shopping portal for its beauty products range. The portal will be the online gateway for consumers to know, understand, buy and gift the exclusive Dabur Uveda range of skincare products.

In May 2011, Dabur India Ltd acquired Ajanta Pharma’s over-the-counter energizer brand ’30-Plus’.

2012
- Namaste Cosmeticos Ltd, has been added as the Company's new step down subsidiary Company in Brazil.
- Dabur India has expanded its range of fruit juices viz. Réal Activ.'

Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback